11 July 2025 · Data exclusivity and market protection periods prevent generic or biosimilar competition for at least 10 years after the originator medicine is licensed.
11 July 2025 · Patents allow the inventor a finite period of monopoly in exchange for publicising the idea. We explain how they work with respect to medicines.
11 July 2025 · New medicines have several protections against competition. Other factors influence availability of generics or biosimilars after loss of exclusivity.